|
Questions?
Want to order by phone?
Call us toll free: (800) 516-4343
Want
to order by mail or fax?
Click
here to download an order form.
Quantifying
Disease Management Return-on-Investment: Trends, Metrics, Evaluations,
Transparency and Reality
What's the best way to calculate
the
return-on-investment (ROI) of your disease management
(DM) programs?
Is there a standardized methodology for evaluating programs?
And
what ROI are employers currently seeing from their DM
programs?
The Managed Care Information
Center is proud to introduce the new report, "Quantifying
Disease Management Return-on-Investment: Trends, Metrics, Evaluations,
Transparency and Reality." This 50-page
special report contains insider information from three
leading experts in DM analytics. They review key principles
in
calculating ROI, how to establish metrics for evaluating DM programs,
and common mistakes in measuring ROI.
They also share some relevant case studies for comparison.
Back
to Order Form
"Quantifying
Disease Management Return-on-Investment: Trends, Metrics, Evaluations,
Transparency and Reality" contains commentary from:
- Ron
Z. Goetzel, Ph.D., Director,
Cornell University Institute for Health and
Productivity Studies; and VP of Consulting and
Applied
Research, Thomson Healthcare
- Thomas
Wilson, Ph.D., DrPH, Epidemiologist,
Trajectory®
Healthcare, LLC
- Matthew McGinnis, Senior
Director of the
Center for Health
Research,
Healthways Inc.
Get information and insight from
our
experts on:
- Key considerations when
evaluating an ROI methodology
- What are the strengths and
weaknesses of current ROI methodologies, including:
- Propensity Score Methods
- Retrospective ROI
- Pre-intervention/post-intervention
studies
- Annual qualification
- Prospective ID
- Longitudinal or time series
analysis
- Participant/non-participant
- The relationship between 10
modifiable risk factors and healthcare costs
- Why does so much variability
exist in current ROI methodologies?
- Results of published DM case
studies on ROI
from
- Dow Chemical
- Citibank
- Procter & Gamble
- Critique of peer-reviewed
literature studies on DM ROI
- Trajectory
Healthcare’s five critical principles in ROI measurement
- American
Healthways’s 8 steps in evaluating historical ROI versus
Month After Identification methodologies
View the full table of contents
online at: http://healthresourcesonline.com/edu/DMROI/TOC.htm
Back
to Order Form
|
